The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A meta-analysis of cardiac toxicity of concurrent epirubicin and trastuzumab in early breast cancer.
 
Minghan Yang
No Relationships to Disclose
 
Chiun-Sheng Huang
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiich Sankyo; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Daiich Sankyo; Roche
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); EirGenix (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Dwan-Ying Chang
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo Pharmaceutical; Eisai; Lilly O.; MSD; Novartis; Ono Pharmaceutical; Pfizer; Pierre Fabre; Roche; Sanofi; TTY Biopharm
Consulting or Advisory Role - AstraZeneca; Lilly O.; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo Pharmaceutical
 
I-Chun Chen
No Relationships to Disclose
 
Ching-Hung Lin
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer
 
Yen-Shen Lu
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; EuroPharma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis